Auddia Inc. (NASDAQ: AUUD) today spotlighted Influence Healthcare, a healthtech company that leverages artificial intelligence and vertical integration to empower surgeons to lead value-based care (VBC) adoption in high-spend specialties such as spine and total joint surgery. The announcement comes as Auddia prepares to file its Form S-4 with the Securities and Exchange Commission later this week, a key step in the merger process that will combine Auddia with Thramann Holdings LLC to form McCarthy Finney.
Influence Healthcare is designed as a structural alternative to hospital employment and private-equity rollups, offering a third path where surgeons retain governance authority and episode-based economics flow to clinicians. The platform uses AI workflows to automate documentation, coding, episode validation, care-pathway coordination, staffing, supply chain, and logistics, allowing surgeons to focus on patient care rather than administrative tasks. "Healthcare is about a physician and patient entering into a relationship to optimize delivery of the highest quality care," said Jeff Thramann, M.D., CEO of Auddia and Founder of Influence Healthcare. "Only the physician has the knowledge, relationship with the patient, and clinical authority to make the many real-time decisions required to deliver the highest quality care at the lowest possible price."
The model organizes surgeons into vertically integrated Value Based Enterprises (VBEs) that contract for bundled case-rate payments. These VBEs are supported by advanced AI systems, which post-merger will leverage shared AI services from McCarthy Finney to deploy agentic-AI workflows that automate prior-authorization, care-pathway adherence monitoring, and communication across the episode. "AI should not replace physicians, it should replace the administrative friction that prevents physicians from practicing at the top of their license," Dr. Thramann added. Influence Healthcare's initial focus is on spine and total joint surgery, with plans to expand to additional specialties and markets through physician-led VBEs.
The merger, announced on February 17, 2026, will combine Auddia with Thramann Holdings, which fully owns LT350, Influence Healthcare, and Voyex. Upon closing, the combined entity will be renamed McCarthy Finney and trade under the ticker MCFN. McCarthy Finney is an AI holding company that will deliver AI and Web3 services to its four portfolio companies. LT350 is a distributed AI data center company with patents on a solar parking lot canopy infrastructure platform, while Voyex is a travel services platform leveraging agentic AI and fintech. Auddia's current audio AI platform includes the faidr app and Discovr Radio.
The S-4 filing will contain a proxy statement and prospectus, providing important information about the merger. Auddia urges investors to read these documents carefully when available. The company's mission is to leverage technology and value-based enterprises to build an alternative healthcare system that minimizes corporate control over clinical practice and enhances physician autonomy. For more information about Influence Healthcare, visit www.influencehealthcare.com.
